Tirzepatide Peptide 40mg – Advanced Dual Agonist Peptide for Research
Product Overview
Tirzepatide Peptide 40mg is a cutting-edge dual agonist compound designed for advanced metabolic and peptide research. Acting on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, Tirzepatide 40mg has become one of the most studied peptides for its powerful effects on glucose regulation, appetite control, and body composition support.
Available in a Tirzepatide 40mg vial or Tirzepatide 40mg pen format, this research-grade peptide ensures consistent potency and reliable results for scientific study.
Key Features and Benefits
- High-Purity Formula: Research-grade Tirzepatide 40mg peptide with verified purity and quality.
- Dual Receptor Mechanism: Targets both GLP-1 and GIP pathways for comprehensive metabolic insight.
- Supports Advanced Metabolic Studies:Â Used in research exploring insulin signaling, fat metabolism, and energy balance.
- Flexible Research Formats: Available as Tirzepatide 40mg vials and Tirzepatide 40mg pens for precise dosing and easy laboratory use.
- Stable and Reliable Compound:Â Manufactured under strict lab conditions to maintain peptide integrity.




